Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy PetMed Express stock

Learn how to easily invest in PetMed Express stock.

PetMed Express is a pharmaceutical retailers business based in the US. PetMed Express shares (PETS) are listed on the NASDAQ and all prices are listed in US Dollars. PetMed Express employs 212 staff and has a trailing 12-month revenue of around $262.3 million.

How to buy PetMed Express stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – PETS. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

PetMed Express stock price (NASDAQ: PETS)

Use our graph to track the performance of PETS stocks over time.

PetMed Express shares at a glance

Information last updated 2023-01-25.
Latest market close$21.15
52-week range$17.08 - $28.25
50-day moving average $19.08
200-day moving average $20.89
Wall St. target price$20.67
PE ratio 26.8961
Dividend yield $1.2 (5.89%)
Earnings per share (TTM) $0.77

Buy PetMed Express stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy PetMed Express stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PetMed Express price performance over time

Historical closes compared with the close of $21.15 from 2023-01-26

1 week (2023-01-20) 13.47%
1 month (2022-12-28) 23.25%
3 months (2022-10-28) -3.20%
6 months (2022-07-28) -2.80%
1 year (2022-01-28) -18.25%
2 years (2021-01-28) -44.55%
3 years (2020-01-28) 25.13
5 years (2018-01-26) 47.8

Is PetMed Express stock undervalued or overvalued?

Valuing PetMed Express stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PetMed Express's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

PetMed Express's P/E ratio

PetMed Express's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, PetMed Express shares trade at around 27x recent earnings.

That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).

PetMed Express's PEG ratio

PetMed Express's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.58. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PetMed Express's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

PetMed Express's EBITDA

PetMed Express's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $22 million.

The EBITDA is a measure of a PetMed Express's overall financial performance and is widely used to measure a its profitability.

PetMed Express financials

Revenue TTM $262.3 million
Operating margin TTM 7.25%
Gross profit TTM $78.1 million
Return on assets TTM 7.23%
Return on equity TTM 11.21%
Profit margin 5.98%
Book value $6.80
Market capitalisation $436.5 million

TTM: trailing 12 months

PetMed Express share dividends

2%

Dividend payout ratio: 1.54% of net profits

Recently PetMed Express has paid out, on average, around 1.54% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.89% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), PetMed Express shareholders could enjoy a 5.89% return on their shares, in the form of dividend payments. In PetMed Express's case, that would currently equate to about $1.2 per share.

While PetMed Express's payout ratio might seem low, this can signify that PetMed Express is investing more in its future growth.

PetMed Express's most recent dividend payout was on 29 November 2022. The latest dividend was paid out to all shareholders who bought their shares by 16 November 2022 (the "ex-dividend date").

Have PetMed Express's shares ever split?

PetMed Express's shares were split on a 3:1 basis on 3 March 1999. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your PetMed Express shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for PetMed Express shares which in turn could have impacted PetMed Express's share price.

PetMed Express share price volatility

Over the last 12 months, PetMed Express's shares have ranged in value from as little as $17.08 up to $28.2474. A popular way to gauge a stock's volatility is its "beta".

PETS.US volatility(beta: 0.59)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PetMed Express's is 0.5943. This would suggest that PetMed Express's shares are less volatile than average (for this exchange).

PetMed Express overview

PetMed Express, Inc. , together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc.

Frequently asked questions

What percentage of PetMed Express is owned by insiders or institutions?
Currently 4.294% of PetMed Express shares are held by insiders and 80.741% by institutions.
How many people work for PetMed Express?
Latest data suggests 212 work at PetMed Express.
When does the fiscal year end for PetMed Express?
PetMed Express's fiscal year ends in March.
Where is PetMed Express based?
PetMed Express's address is: 420 South Congress Avenue, Delray Beach, FL, United States, 33445
What is PetMed Express's ISIN number?
PetMed Express's international securities identification number is: US7163821066
What is PetMed Express's CUSIP number?
PetMed Express's Committee on Uniform Securities Identification Procedures number is: 716382106

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site